Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naive Patients with Suspected Prostate Cancer.

Francesco Porpiglia, Matteo Manfredi, Fabrizio Mele, Marco Cossu, Enrico Bollito, Andrea Veltri, Stefano Cirillo, Daniele Regge, Riccardo Faletti, Roberto Passera, Cristian Fiori, Stefano De Luca

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: An approach based on multiparametric magnetic resonance imaging (mpMRI) might increase the detection rate (DR) of clinically significant prostate cancer (csPCa). OBJECTIVE: To compare an mpMRI-based pathway with the standard approach for the detection of prostate cancer (PCa) and csPCa. DESIGN, SETTING, AND PARTICIPANTS: Between November 2014 and April 2016, 212 biopsy-naive patients with suspected PCa (prostate specific antigen level
Original languageEnglish
Pages (from-to)282-288
Number of pages7
JournalEuropean Urology
Volume72
Publication statusPublished - Aug 1 2017

Keywords

  • Diagnosis, Magnetic resonance imaging, Prostate cancer, Systematic random biopsy, Targeted biopsy

Fingerprint

Dive into the research topics of 'Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naive Patients with Suspected Prostate Cancer.'. Together they form a unique fingerprint.

Cite this